The Future of Medicine, Today

Pharmacogenomics involves the detection of genetic variations that contribute to the variability in drug effectiveness and toxicity that is observed between given individuals. These genetic differences in the metabolic pathways that affect the individual’s response to various therapeutic drugs make it possible to individualize therapy. Our Clinical Laboratory uses a variety of techniques including Sanger Sequencing, Next Generation Sequencing, and Real-Time PCR to obtain the most reliable result.


Our Pharmacogenomic Capabilities
  • Released 15 new biomarkers in 2016 – this doubled our capability and makes our offerings the most robust testing menu in the industry
  • New testing and reporting capability include predictive assessments and treatment guidance for PTSD, Mental Health and Addiction
Our Pharmacogenetic Panels
  • Addiction
  • ADHD
  • Cardiovascular
  • Mental Health PGx
  • Mental Health Risk
  • Pain
  • PTSD PGx
  • PTSD Risk
  • Prenatal
  • Thrombotic